Biblio
Export 1657 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is C [Clear All Filters]
“Higher Body Mass Index Is Associated with Lower Cortical Amyloid-β Burden in Cognitively Normal Individuals in Late-Life.”, J Alzheimers Dis, vol. 69, no. 3, pp. 817-827, 2019.
, “Impacts of Overweight and Obesity in Older Age on the Risk of Dementia: A Systematic Literature Review and a Meta-Analysis.”, J Alzheimers Dis, vol. 70, no. s1, pp. S87-S99, 2019.
, “Impacts of Overweight and Obesity in Older Age on the Risk of Dementia: A Systematic Literature Review and a Meta-Analysis.”, J Alzheimers Dis, vol. 70, no. s1, pp. S87-S99, 2019.
, “Impacts of Overweight and Obesity in Older Age on the Risk of Dementia: A Systematic Literature Review and a Meta-Analysis.”, J Alzheimers Dis, vol. 70, no. s1, pp. S87-S99, 2019.
, “Impacts of Overweight and Obesity in Older Age on the Risk of Dementia: A Systematic Literature Review and a Meta-Analysis.”, J Alzheimers Dis, vol. 70, no. s1, pp. S87-S99, 2019.
, “Impaired Glucose Tolerance and Reduced Plasma Insulin Precede Decreased AKT Phosphorylation and GLUT3 Translocation in the Hippocampus of Old 3xTg-AD Mice.”, J Alzheimers Dis, vol. 68, no. 2, pp. 809-837, 2019.
, “Inferring the Molecular Mechanisms of Noncoding Alzheimer's Disease-Associated Genetic Variants.”, J Alzheimers Dis, vol. 72, no. 1, pp. 301-318, 2019.
, “Maintain Your Brain: Protocol of a 3-Year Randomized Controlled Trial of a Personalized Multi-Modal Digital Health Intervention to Prevent Cognitive Decline Among Community Dwelling 55 to 77 Year Olds.”, J Alzheimers Dis, vol. 70, no. s1, pp. S221-S237, 2019.
, “Maintain Your Brain: Protocol of a 3-Year Randomized Controlled Trial of a Personalized Multi-Modal Digital Health Intervention to Prevent Cognitive Decline Among Community Dwelling 55 to 77 Year Olds.”, J Alzheimers Dis, vol. 70, no. s1, pp. S221-S237, 2019.
, “Maintain Your Brain: Protocol of a 3-Year Randomized Controlled Trial of a Personalized Multi-Modal Digital Health Intervention to Prevent Cognitive Decline Among Community Dwelling 55 to 77 Year Olds.”, J Alzheimers Dis, vol. 70, no. s1, pp. S221-S237, 2019.
, “Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts.”, J Alzheimers Dis, vol. 68, no. 1, pp. 357-365, 2019.
, “Mild Cognitive Impairment and Dementia Involving Multiple Cognitive Domains in Mexican Urbanites.”, J Alzheimers Dis, vol. 68, no. 3, pp. 1113-1123, 2019.
, “Neuron-Specific Apolipoprotein E4 (1-272) Fragment Induces Tau Hyperphosphorylation and Axonopathy via Triggering Endoplasmic Reticulum Stress.”, J Alzheimers Dis, vol. 71, no. 2, pp. 597-611, 2019.
, “Neuron-Specific Apolipoprotein E4 (1-272) Fragment Induces Tau Hyperphosphorylation and Axonopathy via Triggering Endoplasmic Reticulum Stress.”, J Alzheimers Dis, vol. 71, no. 2, pp. 597-611, 2019.
, “NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats.”, J Alzheimers Dis, vol. 73, no. 2, pp. 723-739, 2019.
, “NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats.”, J Alzheimers Dis, vol. 73, no. 2, pp. 723-739, 2019.
, “O-GlcNAcylation of Amyloid-β Protein Precursor by Insulin Signaling Reduces Amyloid-β Production.”, J Alzheimers Dis, vol. 69, no. 4, pp. 1195-1211, 2019.
, “O-GlcNAcylation of Amyloid-β Protein Precursor by Insulin Signaling Reduces Amyloid-β Production.”, J Alzheimers Dis, vol. 69, no. 4, pp. 1195-1211, 2019.
, “Preliminary Report on the Feasibility and Efficacy of the Modified Atkins Diet for Treatment of Mild Cognitive Impairment and Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 68, no. 3, pp. 969-981, 2019.
, “Quantification of Tau Protein Lysine Methylation in Aging and Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 3, pp. 979-991, 2019.
, “Quantification of Tau Protein Lysine Methylation in Aging and Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 3, pp. 979-991, 2019.
, “A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease.”, J Alzheimers Dis, vol. 67, no. 2, pp. 555-570, 2019.
, “Risk Factors for and Clinical Relevance of Incident and Progression of Cerebral Small Vessel Disease Markers in an Asian Memory Clinic Population.”, J Alzheimers Dis, vol. 67, no. 4, pp. 1209-1219, 2019.
, “Small Molecule Amyloid-β Protein Precursor Processing Modulators Lower Amyloid-β Peptide Levels via cKit Signaling.”, J Alzheimers Dis, vol. 67, no. 3, pp. 1089-1106, 2019.
, “Social Isolation and Cognitive Function in Later Life: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 70, no. s1, pp. S119-S144, 2019.
,